Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Resmetirom: A Breakthrough in the Treatment of Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)
PaperCitations, authors & open-access status
Resmetirom: A Breakthrough in the Treatment of Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 12 citations, 2025 year and gold oa status.
12
Citations
2025
Year
gold
OA Status